Sign in

Sanford Burnham Prebys

@sbpdiscovery.bsky.social
335 followers 1.2K following 86 posts

🔬Since 1976, Sanford Burnham Prebys has been dedicated to pushing biomedical discoveries faster and further toward clinical treatment and therapies that improve human lives. We translate science into health. sbpdiscovery.org

PostsRepliesMedia
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 22/09/2026
Congratulations to the five early career scientists at Sanford Burnham Prebys who were recognized at the 25th annual Fishman Fund awards ceremony. The Fishman Fund supports promising researchers as they build their scientific careers. sbpdiscovery.org/ceremony-cel...
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 19/08/2026
In two back-to-back studies published in Genes & Development, a team led by Anindya Bagchi, PhD, uncovered a new framework for understanding how the PVT1 region regulates MYC activity. sbpdiscovery.org/press/resear... @anindyabagchi.bsky.social
An array of human cancer tissues, including prostate, colon, kidney, intestine and breast, are depicted in samples using fluorescence immunohistochemistry and confocal microscopy. A common denominator: Most are driven by mutations in the MYC gene. Image courtesy of Wellcome Collection.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 12/08/2026
A study from the Tharp lab and collaborators in #ScienceAdvances finds that nearby conditions and nutrients influence how cancer cells evade the immune system and reveals a potential way to stop this protection. sbpdiscovery.org/press/stripp...
sbpdiscovery.org
Stripping away what conceals cancer cells from our immune system - Sanford Burnham Prebys
Study from the Tharp lab finds nearby conditions and nutrients govern how cancer cells avoid immune cells, and how to stop this protection.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 24/07/2026
New research from the Boutros lab, published in BMJ Oncology, found that protein levels differ in lung tumors from men and women. Lung cancer also showed more sex-related protein differences than any other cancer type studied. sbpdiscovery.org/press/biolog... @chenghaozhu.bsky.social
sbpdiscovery.org
Biological sex linked to protein changes in lung adenocarcinoma and other cancers - Sanford Burnham Prebys
Study shows lung adenocarcinoma has strong sex-based proteome differences, while five other cancer types have moderate differences.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 23/07/2026
With Alzheimer’s, tau proteins form noxious knots and gradually disrupt the brain circuits they would otherwise preserve. The Huang lab showed in #ScienceAdvances that a different protein called SORLA offers protection against the effects of these lethal loops. sbpdiscovery.org/press/protec...
An overabundance of SORLA protein protects against a number of biological processes linked to the formation of tau tangles and progression of neurodegeneration. These include reducing the addition of too many phosphate groups to tau, known as hyperphosphorylation. In these biopsy images, less phosphorylated tau—stained to appear green—has accumulated in the bottom sample overexpressing SORLA. Image credit: Tim Huang, Huijie Huang, Sanford Burnham Prebys.Timothy Huang, PhD, assistant professor in the Center for Neurologic Diseases at Sanford Burnham Prebys and Huijie Huang, PhD, is a staff scientist in the Huang lab at Sanford Burnham Prebys.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 20/07/2026
Sanford Burnham Prebys mourns the loss of T. Denny Sanford, whose visionary philanthropy helped shape our Institute and advance biomedical research. sbpdiscovery.org/t-denny-sanf...
sbpdiscovery.org
T. Denny Sanford (1935-2026) - Sanford Burnham Prebys
Renowned philanthropist and businessman T. Denny Sanford passed away July 18, 2026 in his hometown of Sioux Falls, South Dakota. He was 90 years old.
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 13/07/2026
We’re excited to welcome Jill Mesirov, PhD, to Sanford Burnham Prebys as Distinguished Professor and Senior Vice President for Computational Science. sbpdiscovery.org/press/pionee...
Jill Mesirov
000
Reposted by Sanford Burnham Prebys
Healthcare in Europe @healthcare-europe.bsky.social · 05/07/2026
Why does #prostatecancer in some patients grow slowly and remain localized while it becomes aggressive and metastasizes in others? In a new paper led by 🇺🇸 @sbpdiscovery.bsky.social, researchers identify the answer: #tumor methylation.
122
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 17/06/2026
Kevin Tharp, PhD, was awarded a 3 year, $450,000 Ovarian Cancer Research Alliance grant. Tharp will use the new funding to follow up on research findings regarding how high grade serous ovarian cancer circumvents the immune system’s anti-tumor defenses. sbpdiscovery.org/kevin-tharp-...
sbpdiscovery.org
Kevin Tharp awarded $450,000 Ovarian Cancer Research Alliance grant to break down tumor defenses - Sanford Burnham Prebys
The new award will fund research regarding how to bust through the barrier between tumors and immune cells.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 11/06/2026
What can we learn from people who live past 100 in good health? Researchers from the U.S. and Europe gathered at Sanford Burnham Prebys to share new findings from the CIAO Study, an ongoing effort to uncover the secrets of healthy aging and longevity. 🧬🌿 sbpdiscovery.org/press/ciao-s...
sbpdiscovery.org
CIAO Study: 11th annual longevity symposium provides new peeks and possibilities at  longer, healthier lives - Sanford Burnham Prebys
The Cilento Initiative on Aging Outcomes (CIAO) held its 11th annual research symposium at Sanford Burnham Prebys, with more than a dozen scientists and physicians from Europe and the US presenting ne...
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 03/06/2026
🎓 Congratulations to the newest graduates of the Sanford Burnham Prebys Graduate School of Biomedical Sciences! We're proud to welcome these talented scientists to our alumni community and look forward to celebrating their achievements in the years ahead. sbpdiscovery.org/sanford-burn...
sbpdiscovery.org
Sanford Burnham Prebys recognizes 10 doctoral degree recipients - Sanford Burnham Prebys
The Institute’s Graduate School of Biomedical Sciences held its third Commencement ceremony to celebrate new alumni.
030
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/06/2026
Launching 50 for 50: 50 discoveries from 50 years at Sanford Burnham Prebys. Some transformed fields. Some opened doors others walked through. All worth knowing. More stories coming. sbpdiscovery50.org/50-for-50/
50 for 50
50 discoveries that shaped our first 50 years.
Celebrating 50 years of discovery at Sanford Burnham Prebsuy
020
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 22/05/2026
Cholesterol-craving cancers need lipid enzymes to use metabolites for growth |Study finds kinases move cholesterol in the cell to where it can activate a growth pathway in many aggressive cancers. The @bemerling.bsky.social Emerling lab published in #ScienceAdvances. sbpdiscovery.org/press/choles...
Cholesterol-craving cancers need lipid enzymes to use metabolites for growth
021
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 16/04/2026
The Freeze lab and an international team of collaborators discovered a new rare genetic disease that interferes with brain development. They published findings in @hggadvances.bsky.social that identify the faulty mutated gene and show how it interferes with normal cellular function. bit.ly/4vul3h3
sbpdiscovery.org
Researchers identify new genetic disease that interferes with brain development - Sanford Burnham Prebys
Study from the Freeze lab finds that a mutation destabilizes proteins involved in how children grow and mature.
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 10/03/2026
Nearly 40% of U.S. adults have metabolic syndrome, a condition that can lead to liver damage and fibrosis. A new study from Sanford Burnham Prebys highlights LARP6, an RNA-binding protein that helps drive fibrosis and may be a promising therapeutic target. sbpdiscovery.org/press/living...
Skip to content
Sanford Burnham Prebys

Research

Scientists
Education

News

Philanthropy

About

Open Search
Donate
Press Release
Living LARP6: How a protein plays an oversized role in liver fibrosis
Author
Communications
Date
March 9, 2026


Share
In this stained sample of liver tissue with cirrhosis, bands of fibrotic scarring are shown in blue.
In this stained sample of liver tissue with cirrhosis, bands of fibrotic scarring are shown in blue.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/03/2026
Thank you to The San Diego Union-Tribune for helping share the story of Sanford Burnham Prebys as we mark 50 years of discovery and impact. We’re grateful for the spotlight on the people, science and community that have shaped our Institute since 1976. www.sandiegouniontribune.com/2026/02/27/a...
sandiegouniontribune.com
‘A novel approach’: Sanford Burnham Prebys celebrates 50 years of medical exploration
The La Jolla-based research institute continues its founding principle of collaboration across multiple fields
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 13/02/2026
An international team including the Kaufman lab published in Nature.com showing that liver cell stress can both drive cancer and make tumors less resistant to immunotherapy. The findings may help physicians identify which patients are most likely to benefit from existing treatments.
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 12/02/2026
Today, on International Day of #WomenAndGirlsInScience, we gathered for the latest Women in Science Lecture Series. Thank you for the thoughtful and engaging conversation Cheryl Anderson, PhD, MPH, MS and Angela Liou, MD. Grateful to everyone who joined us. #InternationalDayOfWomenAndGirlsInScience
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 04/02/2026
Sanford Burnham Prebys scientists published in @cp-cellreports.bsky.social showcasing a new approach for measuring the activity of enzymes linked to cell death and a more complicated picture where protein activation cannot always be presumed by protein production. sbpdiscovery.org/press/metall...
Cells that are dysfunctional due to aging or mutation are removed through a process of programmed cell death, known as apoptosis. Image credit: Kateryna Kon/Sanford Burnham Prebys.

https://sbpdiscovery.org/press/metallic-markers-make-direct-measurement-of-protein-activity-possible/


Study shows how new chemical probes can count individual enzymes and discern their activity levels, may inform discovery of new treatments

Cells operate on rules not vibes, including when on the precipice of persisting or perishing. Yet, with prior research methods, scientists studying this phenomenon had to infer how cells choose to sustain themselves or self-destruct based on the output of their protein factories.

While much more advanced than a pundit’s vibe check, these analyses were constrained by the inability to account for the activity of these proteins after their construction.

Scientists at Sanford Burnham Prebys Medical Discovery Institute and Wroclaw University of Science and Technology published findings January 10, 2026, in Cell Reports demonstrating a new approach for measuring their activity. The researchers also revealed a more complicated picture in which protein activation cannot always be presumed by protein production.

Many cells in our bodies are routinely monitored for signs that they need to be removed. Like a gardener pruning dead or diseased branches, cells that are dysfunctional due to aging or mutation are removed through a process of programmed cell death, known as apoptosis. One of cancer’s calling cards is that cancerous cells ignore apoptosis and grow to become harmful tumors.

“Scientists have defined a lot of the cellular signals involved in apoptosis,” said Guy Salvesen, PhD, professor emeritus at Sanford Burnham Prebys and senior and co-corresponding author of the manuscript. “To better understand how these signals work, we need to know how many active copies of an enzyme it takes to trigger apoptosis in a cell.”

The research team needed to trac…
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/02/2026
Join us on February 11 for the next event in the Women in Science Lecture Series at Sanford Burnham Prebys, featuring a lecture and fireside chat that highlight the groundbreaking work and perspectives of women leaders in biomedical science. Must RSVP to attend: lnkd.in/gzkXQRrm
Women in Science Lecture Series - Inspiring the Next Generation of Leaders in Biomedical Research
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 30/01/2026
Advancing Together: 50 Years of Sanford Burnham Prebys - For 50 years, bold ideas, dedicated scientists, and a shared commitment to discovery have shaped who we are today. Join us as we celebrate this milestone year and look ahead to the next 50. youtu.be/Q4hNMzBq7N0?...
Two scientists looking at a petri dish.
Celebrating 50 Years of Sanford Burnham Prebys - For 50 years, bold ideas, dedicated scientists, and a shared commitment to discovery have shaped who we are today. Join us as we celebrate this milestone year and look ahead to the next 50.
010
Reposted by Sanford Burnham Prebys
Epigenetics Podcast @epigeneticspod.bsky.social · 19/01/2026
In this episode of the Epigenetics Podcast, we talked with Will Wang from @sbpdiscovery.bsky.social about his work on muscle stem cell repair, regeneration, and aging, exploring spatial-omics and machine learning. #podcast #epigenetics Listen here: activemotif.com/podcasts-wil...
063
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 18/11/2025
New research from Sanju Sinha, PhD, introduces DeepTarget, a tool that predicts both primary and secondary targets of cancer drugs. It could help repurpose existing medicines for more patients. sbpdiscovery.org/press/comput...
DeepTarget’s predictions are based on the principle that removing a gene encoding the protein target of a given drug through CRISPR-Cas9 gene editing can mimic the inhibitory effects of that drug. The tool was built by leveraging large-scale genetic and drug screening experiments with comprehensive data for 1450 drugs across 371 cancer cell lines. Image credit: Sanju Sinha, Sanford Burnham Prebys.
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 07/11/2025
Meet Rouven Arnold, PhD, a postdoc in Peter Adams’ lab at Sanford Burnham Prebys. He studies how aging changes our cells—with the goal of preventing diseases like heart disease, cancer, and dementia. Learn what drives his work and his path into science. ➡️ bit.ly/47PtecX
bit.ly
Q & A with Postdoctoral Researcher Rouven Arnold, PhD, from the Adams Lab - Sanford Burnham Prebys
Meet one of our early-career scientists: Rouven Arnold, PhD
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 03/11/2025
Scientists at Sanford Burnham Prebys, the University of Minnesota and Duke University report in Nature that “biased modulators” can target GPCRs more precisely—expanding potential drug targets and reducing side effects. www.nature.com/articles/s41...
122
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 23/10/2025
“Once we find the players that drive disease, we can find drugs to help,” says Sanjeev Ranade, PhD. New study reveals a key protein linked to heart defects in Down syndrome. 🧬❤️ sbpdiscovery.org/press/huntin...
Sanjeev S. Ranade, PhDIn this colorized karyotype of chromosomes, the three copies of chromosome 21 are indicated. Trisomy 21 causes Down syndrome, and half of all such cases also involve congenital heart defects.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 16/10/2025
🧬 Biomedical Sciences PhD Applications Now Open! Do you want to explore the science behind human health and disease? Our program is looking for curious and driven researchers ready to tackle the most pressing questions in biology and medicine. sbpdiscovery.org/education/gr...
Applications are now open for Sanford Burnham Prebys Graduate School of Biomedical Sciences. The Deadline is December 1, 2025.
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 07/10/2025
We’re pleased to announce that Paul Boutros, PhD, MBA, has been named the new director of the National Cancer Institute (NCI) designated cancer center at Sanford Burnham Prebys Medical Discovery Institute. Read all about it! sbpdiscovery.org/press/paul-b...
Paul Boutros, PhD, MBA
020
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/10/2025
👏 Congratulations to Xueqin Sherine Sun, PhD, on receiving a $600,000 grant from the V Foundation for Cancer Research to study glioblastoma, one of the most common and deadly brain cancers. sbpdiscovery.org/xueqin-sun-a...
Xueqin (Sherine) Sun, PhD
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 25/09/2025
What connects survival, science + diabetes care? Adam Heller, PhD. At 92, this Holocaust survivor, scientist + engineer shares how his innovations changed how millions manage diabetes. 🎙️Hear his remarkable story in Episode 5 of the podcast. 👀On YouTube: youtu.be/TEhPlF29yl4?...
Sensing Sugar Spikes and the man who made the invisible visible.
Episode 5 of The Discovery Dialogues podcastSanford Burnham Prebys Medical Discovery Institute scientists Ani Deshpande, PhD, and Pamela Itkin-Ansari, PhD,
110
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 16/09/2025
Today, 62 National Cancer Institute (NCI)–Designated Cancer Centers issued a joint statement underscoring the importance of HPV vaccination. #HPVvaccine #HPVvax #EndHPVCancers
HPV vaccination prevents 6 types of cancer. Get vaccinated and share the facts.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 10/09/2025
🔬 New research from the @anideshpande.bsky.social Deshpande lab at Sanford Burnham Prebys. The study demonstrates how public genomic screening data can be used to uncover a new genetic vulnerability in synovial sarcoma. 👏 Shout out to Rema Iyer, PhD lead author of the manuscript.
Sizing up a weakness in synovial sarcoma’s genes
111
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 14/08/2025
For decades, scientists thought MYOD was just a muscle-builder. But new research from Sanford Burnham Prebys shows this gene has a Jekyll-and-Hyde side—able to switch from activating muscle genes to silencing them. sbpdiscovery.org/press/muscle...
Myogenic determination gene number 1 (MYOD) protein immunofluorescence in myofibers.
021
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 05/08/2025
Proud to host six high school interns from the Preuss School for a hands-on research experience at Sanford Burnham Prebys. 👏 Thanks to Peggy & Peter Preuss and Debby & Wain Fishburn for making it possible! sbpdiscovery.org/preuss-schoo...
sbpdiscovery.org
Preuss School interns wrap up unforgettable research experience - Sanford Burnham Prebys
Aspiring biomedical researchers and health care professionals gained hands-on research training at Sanford Burnham Prebys.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/08/2025
New research from the Marth Lab: Most blood glycoproteins are easy to spot—but finding the rare ones is like searching for Waldo across every book. 🧠🧬 🔗 Read more: sbpdiscovery.org/press/signal... #Biomedicine #SanfordBurnhamPrebys #NatureCommunications #Science
After comparing proteins in the bloodstreams of normal mice and mice lacking Mrc1, the team found the accumulation of 244 mannosylated blood plasma proteins to double or more of the amounts found in normal mice due to Mrc1 no longer keeping the levels in check. The scientists then took a closer look at the newly identified ligands. They used bioinformatics to review and depict these hundreds of proteins by their functions. Image credit: Jamey Marth and Mayank Saraswat, Sanford Burnham Prebys.
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 30/07/2025
Meet Meena Sudhakaran, PhD, a postdoc in the Kersten Lab at Sanford Burnham Prebys. She’s advancing cancer immunology to improve immunotherapy for breast cancer. Read more about her journey into science: sbpdiscovery.org/q-and-a-with... #CancerResearch #PostdocLife
sbpdiscovery.org
Q & A with Postdoctoral Researcher Meena Sudhakaran, PhD, from the Kersten Lab - Sanford Burnham Prebys
Meet one of our early-career scientists: Meena Sudhakaran, PhD. She studies cancer immunology to improve immunotherapy for breast cancer.
000
Reposted by Sanford Burnham Prebys
The American Journal of Pathology @ajpathology.bsky.social · 29/07/2025
#ArticleinPress: Peroxisome Proliferator-activated Receptor Agonist IVA337 Alleviates Inflammation and Fibrosis in MASH by Restoring Lipid Homeostasis. @ucsandiego.bsky.social and @sbpdiscovery.bsky.social. #OpenAccess text: ajp.amjpathol.org/article/S000...
ajp.amjpathol.org
Peroxisome Proliferator-activated Receptor Agonist IVA337 Alleviates Inflammation and Fibrosis in MASH by Restoring Lipid Homeostasis
Metabolic dysfunction-associated steatohepatitis (MASH), an advanced stage of metabolic dysfunction-associated steatotic liver disease (MASLD), is characterized by significant hepatic fibrosis and inf...
031
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 26/07/2025
A promising advance for pancreatic cancer published Cancer Cell: Blocking macropinocytosis reduces fibrosis around pancreatic tumors, improving immune cell access & boosting response to chemo & immunotherapy in mice. sbpdiscovery.org/press/reshap... @cosimocommisso.bsky.social @yijuan.bsky.social
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 16/07/2025
Big congrats to grad students Aashna Lamba & Ashley Neil at @SBPdiscovery—named 2025 CIRM Predoctoral Fellows! 🌟 Lamba’s research could help hearts heal after injury ❤️ Neil is exploring brain inflammation in Alzheimer’s 🧠 #SanfordBurnhamPrebys #RegenerativeMedicine #CIRM #STEM
Aashna Lamba - Lamba is investigating the use of genetic reprogramming to help the heart heal after being injured.Ashley Neil - Neil is studying a neurotransmitter that influences brain cell inflammation and activity in Alzheimer's disease.
020
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 02/07/2025
📣 Welcome Michael Karin, Ph.D., to Sanford Burnham Prebys! He joins as director of the new Center for Metabolic and Liver Diseases and will continue his pioneering work on chronic inflammation and cancer. sbpdiscovery.org/press/leadin...
sbpdiscovery.org
Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys - Sanford Burnham Prebys
Karin will direct the Center for Metabolic and Liver Diseases and continue his studies on inflammation and cancer.
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 25/06/2025
What if the key to major medical breakthroughs is already sitting in clinical databases—just waiting to be unlocked? Sanford Burnham Prebys CEO David Brenner shares why tapping into electronic health records could transform research and care. Read more: www.sandiegouniontribune.com/2025/06/23/o...
sandiegouniontribune.com
Opinion: Health database could provide key insights to improve care
In every body and in everybody, there is an enormous, diverse and changing array of medical and health information, from longitudinal data like our weight and blood pressure over the years to the b…
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 05/06/2025
Cheers to the newest grads of the Sanford Burnham Prebys Graduate School of Biomedical Sciences! 🎓🔬♥️ Their hard work, perseverance, and curiosity reflect the spirit of our graduate program's motto: “Knowledge is the power to heal.” Congrats to these rising scientists. More: bit.ly/3HFmyEB
bit.ly
Sanford Burnham Prebys celebrates newest graduate school alumni - Sanford Burnham Prebys
The Graduate School of Biomedical Sciences held its 2025 Commencement ceremony to celebrate four recent graduates.
001
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 04/06/2025
🧠 Could HIV drugs help lower #Alzheimer’s risk? New research from Sanford Burnham Prebys, led by Jerold Chun, MD, PhD, found that patients taking #HIV drugs blocking #reversetranscriptase had fewer cases of Alzheimer’s—pointing to a potential drug target. More: bit.ly/4kuxvHU
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 03/06/2025
Centenarians in Cilento are thriving thanks to a Mediterranean way of life. The CIAO Study 🌿 reveals they’re biologically younger, with resilient immune systems & strong social ties—offering real clues to how we can all age better. More: bit.ly/45HjqCf #CIAOstudy #longevity #healthyaging
bit.ly
CIAO Study: Lessons learned on living longer and better (with more to come) - Sanford Burnham Prebys
A select group of scientists from around the world gathered in the small town of Acciaroli in the Cilento-Salerno region of Italy to review a decade’s worth of research in the ongoing Cilento Initiative on Aging Outcomes (CIAO), a longitudinal study of local residents 100 years and older.
110
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 31/05/2025
Evan Snyder, MD, PhD, professor in the Center for Neurologic Diseases at Sanford Burnham Prebys, was named a Fellow of the Child Neurology Society for his clinical expertise and pioneering research in #pediatricneuroscience and #stemcellbiology. 🧠 Learn more: 🔗 bit.ly/4jATHio
bit.ly
Evan Snyder named Fellow of the Child Neurology Society - Sanford Burnham Prebys
Evan Snyder, MD, PhD, has been named a Fellow of the Child Neurology Society, honoring a distinguished career and significant contributions in the field of child neurology.
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 30/05/2025
From cancer and aging to immunotherapy and AI, these new PhDs are already making an impact—and they’re just getting started. 👏 Learn more about how we’re training tomorrow’s scientists: vist.ly/3n5mjza #SBPgrad #PhDlife #FutureOfScience #BiomedicalResearch #CancerResearch #Immunotherapy
010
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 30/05/2025
The Prebys Foundation has announced a $7M emergency funding package for seven top-tier biomedical research institutions in San Diego, a global hub of scientific innovation, including Sanford Burnham Prebys. Learn more: 🔗 bit.ly/4kiJ84H
bit.ly
Prebys Foundation awards $1 million to Sanford Burnham Prebys as part of emergency support to local biomedical research institutions - Sanford Burnham Prebys
The Prebys Foundation announced this week an emergency response package totaling $7 million to seven leading research institutions in San Diego — a global hub and leader in biomedical science and innovation.
011
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 29/05/2025
🎙️ Catch Ani Deshpande, PhD, in episode 151 of the @epigeneticspod.bsky.social‬‬ where he discusses his work on epigenetic regulation in #AML, and the use of #CRISPR and high throughput screens for drug discovery. ▶️ YouTube: vist.ly/3n5jemi ᯤ Spotify: vist.ly/3n5jemj
003
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 28/05/2025
Check out our Q&A with scientists and podcasters Ani Deshpande & Pam Itkin-Ansari! Their podcast 𝑇ℎ𝑒 𝐷𝑖𝑠𝑐𝑜𝑣𝑒𝑟𝑦 𝐷𝑖𝑎𝑙𝑜𝑔𝑢𝑒𝑠 is blowing minds—venom, insulin, and Ozempic all in one. 🎧💉 Listen: bit.ly/3Fmu4nl
bit.ly
Scientists and podcasters - Sanford Burnham Prebys
Sanford Burnham Prebys scientists Ani Deshpande, PhD, and Pamela Itkin-Ansari, PhD, bring dramatic stories of scientific achievement to life.
000
Sanford Burnham Prebys @sbpdiscovery.bsky.social · 20/05/2025
Cutting NIH funding means fewer cures, fewer trials, and slower progress. San Diego researchers are speaking out. 🧬 Dr. Kurt Marek of Sanford Burnham Prebys joined the call to protect science. 🔗 www.10news.com/news/local-n... #FundScience #NIH
10news.com
San Diego County supervisor & local researchers make voices heard on preserving NIH funding
"We are here today to sound the alarm on the devastating cuts and disruptions to the National Institutes of Health,” Supervisor Terra Lawson-Remer said.
000